Trial Profile
In Market Utilisation of Liraglutide Used for Weight Management in the UK: a Study in the CPRD Primary Care Database
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Nov 2022
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 08 Nov 2022 Status changed from recruiting to completed.
- 27 Mar 2019 Planned End Date changed from 15 Jan 2019 to 15 Jul 2022.
- 27 Mar 2019 Planned primary completion date changed from 15 Jan 2019 to 15 Jul 2022.